Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial-Reference-Cited by-同舟云学术

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

Published:2018-08 Issue:10148 Volume:392 Page:637-649
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

O'Neil Patrick M,Birkenfeld Andreas L,McGowan Barbara,Mosenzon Ofri,Pedersen Sue D,Wharton Sean,Carson Charlotte Giwercman,Jepsen Cecilie Heerdegen,Kabisch Maria,Wilding John P H

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Regarding obesity as a disease: evolving policies and their implications;Kyle;Endocrinol Metab Clin North Am,2016

2. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity: executive summary;Garvey;Endocr Pract,2016

3. Obesity: preventing and managing the global epidemic: report of a WHO consultation on obesity,1997

4. Management of obesity;Bray;Lancet,2016

5. The medical care costs of obesity: an instrumental variables approach;Cawley;J Health Econ,2012

Cited by 515 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An insoluble cellulose nanofiber with robust expansion capacity protects against obesity;International Journal of Biological Macromolecules;2024-10

2. Differential Efficacy of Weight Loss Interventions in Patients with Versus Without Diabetes;Diabetes Therapy;2024-09-14

3. Comparison of glucagon-like peptide-1 receptor agonists vs. placebo on any cardiovascular events in overweight or obese non-diabetic patients: a systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-09-11

4. An antifibrotic compound that ameliorates hyperglycaemia and fat accumulation in cell and HFD mouse models;Diabetologia;2024-09-09

5. Semaglutide and blood pressure: an individual patient data meta-analysis;European Heart Journal;2024-09-01